Comparison of CT- and radiograph-based post-implant dosimetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software

Strahlentherapie und Onkologie

Volumn 182, Issue 2, 2006, Pages 96-101

  Siebert, Frank André ^a   Kohr, Peter ^a   Kovács, György ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Brachytherapy; Dosimetry; Postplanning; Reconstruction algorithm; Seed 125I

Indexed keywords

IODINE 125;

AB INITIO CALCULATION; ALGORITHM; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DOSIMETRY; HUMAN; INSTRUMENTATION; MEASUREMENT ERROR; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIOISOTOPE THERAPY; TREATMENT PLANNING; X RAY FILM;

ALGORITHMS; BRACHYTHERAPY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IODINE RADIOISOTOPES; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SOFTWARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 31744451831     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1465-4     Document Type: Article

References (23)

1. Aebersold DM, Isaak B, Thalmann G, et al. Applicability and dosimetric impact of ultrasound-based preplanning in high-dose-rate brachytherapy of prostate cancer. Strahlenther Onkol 2004;180:351-7.
2. Al-Quasieh B, Ash D, Bottomley DM, et al. Impact of prostate volume evaluation by different observers on CT-based post-implant dosimetry. Radiother Oncol 2002;62:267-73.
3. Ash D, Flynn A, Battermann J, et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000;57:315-21.
4. Galalae R, Kovács G, Schultze J, et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:81-90.
5. Galalae RM, Loch T, Riemer B, et al. Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer. Strahlenther Onkol 2004;180:582-9.
6. Gong L, Cho PS, Han BH, et al. Ultrasonography and fluoroscopic fusion for prostate brachytherapy dosimetry. Int J Radiat Oncol Biol Phys 2002; 54:1322-30.
7. Hammer J. J-125 seed implantation in the treatment of cancer of the prostate. Strahlenther Onkol 1991;167:63-81.
8. Haworth A, Ebert M, St. Clair S, et al. Impact of selection of post-implant technique on dosimetry parameters for permanent prostate implants. Brachytherapy 2005;4:146-53.
9. Hoinkis C, Hakenberg OW, Lehmann D, et al. Evaluation of dose-volume histograms after prostate seed implantation. Strahlenther Onkol 2004;180:550-6.
10. Julow J, Viola A, Major T, et al. Iodine-125 brachytherapy of brain stem tumors. Strahlenther Onkol 2004;180:449-54.
11. Kaulich TW, Lamprecht U, Paulsen F, et al. Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125. Strahlenther Onkol 2002;178:548-55.
12. Kumar PP, Good RR, Hussain MB, et al. Simple, accurate, safe and cost-effective percutaneous transperineal template technique for permanent 125-iodine interstitial brachytherapy of prostate cancer. Strahlenther Onkol 1986;162:713-9.
13. 125I prostate brachytherapy dose evaluation. Med Phys 2003;30:1897-908.
14. Martin T, Baltas D, Kurek R, et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 2004;180:225-32.
15. Maurer U, Pinkawa M, Gagel B, et al. Optimierungsmöglichkeiten der Seed-implantation durch interactive TRUS-Online-Dosimetrie beim Prostatakarzinom. Strahlenther Onkol 2001;177:Sondernr 1:67.
16. Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999;44:789-99.
17. Narayanan S, Cho PS, Marks RJ. Three-dimensional seed reconstruction from an incomplete data set for prostate brachytherapy. Phys Med Biol 2004; 49:3483-94.
18. Pinkawa M, Maurer U, Mulhern A, et al. Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity I-125. Strahlenther Onkol 2003;179:417-22.
19. Siebert FA, Kohr P, Kovács G. The design and testing of a solid phantom for the verification of a commercial 3D seed reconstruction algorithm. Radiother Oncol 2005;74:169-75.
20. Todor DA, Zaider M, Cohen GN, et al. Intraoperative dosimetry for prostate implants. Phys Med Biol 2003;48:1153-71.
21. Tubic D, Zaccarin A, Beaulieu L, et al. Automated seed detection and three-dimensional reconstruction. II. Reconstruction of permanent prostate implants using simulated annealing. Med Phys 2001;28:2272-9.
22. Varian Medical Systems. Customer technical bulletin: problems with the three film isocentric reconstruction method in VariSeed™. CBE-VE-381A. Palo Alto (CA): Varian Medical Systems, 2004.
23. Wirth MP, Hermann T, Alken P, et al. Empfehlungen zur Durchführung der alleinigen permanenten, interstitiellen Brachytherapie beim lokal begrenzten Prostatakarzinom. Strahlenther Onkol 2002;178:115-9.